Dr. Donald W. Miller, Jr., MD: Measles vs. MMR Vaccine- Risks & Benefits

“The risks of the MMR vaccine are greater than the risks of having measles. This fact is gradually coming to light.”
Here are a few excerpts from an excellent article written by Dr. Miller at LewRockwell.com . I encourage you to read the full article, and get that critical thinking juice going:
MMR vaccination for measles provides immunity against the virus that causes this disease, and people are spared having to suffer through its debilitating manifestations and be subject to possible complications. The MMR shot, however, does not confer lifelong immunity against measles. It only lasts for several years. Booster shots are required, which studies show to be less effective than the initial one.
Health officials, both in the U.S. and UK, blame unvaccinated people and the “anti-vaxxers” for these outbreaks. Assisted by a compliant media, they downplay the fact that the vast majority of people who are contracting measles have been fully vaccinated against it—more than 95 percent in some outbreaks

The key question, of course, which officials and pundits do not ask (preferring instead to censure “anti-vaxxers”), is: Why would an unvaccinated person pose a danger to the vaccinated population if the vaccine they had is effective and really works?

One benefit of having measles is that a person so infected will then have lifelong, permanent immunity to it. Mothers transfer antibodies against measles to their babies, which protect them from this disease during their early critical months of life. The MMR shot, however, does not provide lifelong immunity to measles. It only lasts several years, and successively less effective booster shots are required

There is a second, major benefit of measles that health authorities overlook. Measles helps a child’s immune system grow strong and mature

Could the fact that cancer has now become a leading cause of death in children be connected to vaccinations? Only a well-controlled, randomized, blinded, long-term scientific trial would be able to conclusively answer this question. But societal entities that could fund such a study, like the government’s National Institutes of Health (NIH), drug companies that make the vaccine, or the CDC do not feel that it is necessary to conduct one

Read the article @ LRC: Click Here
*Donald Miller (send him mail) is a retired cardiac surgeon and Emeritus Professor of Surgery at the University of Washington School of Medicine in Seattle. He is a member of Doctors for Disaster Preparedness and writes articles on a variety of subjects for LewRockwell.com . His web site is www.donaldmiller.com.